IL-6 detection in multiple sclerosis brain

被引:135
|
作者
Maimone, D [1 ]
Guazzi, GC [1 ]
Annunziata, P [1 ]
机构
[1] UNIV SIENA,INST NEUROL SCI,I-53100 SIENA,ITALY
关键词
interleukin-6; multiple sclerosis; central nervous system; astrocyte;
D O I
10.1016/S0022-510X(96)00283-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
By using a double-label immunohistochemistry technique, we demonstrated the presence of interleukin-6 (IL-6) in acute and chronic active plaques from the brain of six patients with multiple sclerosis (MS). IL-6 was mainly associated with astrocytes and rarely with macrophages or mononuclear infiltrating cells. The pattern of distribution for IL-6 immunoreactivity was similar to that of HLA-DR expression, but the two molecules almost never colocalized on the same cell. Our data indicate that in MS central nervous system IL-6 is predominantly located within resident glial cells which are concentrated at the sites of ongoing demyelination and immune activation. Although IL-6 exhibits several proinflammatory activities, indirect evidence suggests that the cytokine may also play an immunomodulatory role in inflammatory demyelinating disorders. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:59 / 65
页数:7
相关论文
共 50 条
  • [41] Fitness Shifts the Balance of BDNF and IL-6 from Inflammation to Repair among People with Progressive Multiple Sclerosis
    Devasahayam, Augustine Joshua
    Kelly, Liam Patrick
    Williams, John Bradley
    Moore, Craig Stephen
    Ploughman, Michelle
    BIOMOLECULES, 2021, 11 (04)
  • [42] Elevated T-cell production of IL-17 in transverse myelitis and multiple sclerosis leads to induction of astrocyte IL-6
    Graber, JJ
    Allie, SR
    Mullen, KM
    Jones, MV
    Wang, D
    Krishnan, C
    Nath, A
    Kaplin, AL
    Kerr, DA
    Calabresi, PA
    NEUROLOGY, 2006, 66 (05) : 311 - 311
  • [43] Kinetics of IL-6 Production Defines T Effector Cell Responsiveness to Regulatory T Cells in Multiple Sclerosis
    Trinschek, Bettina
    Luessi, Felix
    Haas, Juergen
    Wildemann, Brigitte
    Zipp, Frauke
    Wiendl, Heinz
    Becker, Christian
    Jonuleit, Helmut
    PLOS ONE, 2013, 8 (10):
  • [44] Targeting IL-6/STAT3 pathway with small-molecule compounds for multiple sclerosis therapy
    Yang, Yuhong
    Li, Chenglong
    Nuro-Gyina, Patrick
    Lovett-Racke, Amy
    Racke, Michael
    JOURNAL OF IMMUNOLOGY, 2014, 192
  • [45] Impact of HLA-DRB alleles on the role of IL-6 promoter polymorphism in an Iranian population with multiple sclerosis
    Shahbazi, M.
    Ebadi, H.
    Fathi, D.
    Roshandel, D.
    Mahammadhoseeni, M.
    Rashidbaghan, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 272 - 272
  • [46] Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis
    Hasegawa, M
    Sato, S
    Fujimoto, M
    Ihn, H
    Kikuchi, K
    Takehara, K
    JOURNAL OF RHEUMATOLOGY, 1998, 25 (02) : 308 - 313
  • [47] The IL-6 promoter polymorphism is associated with severity and disability in systemic sclerosis
    Sfrent-Cornateanu, R.
    Mihai, C.
    Ionescu, R.
    Stoica, V.
    Bara, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 522 - 522
  • [48] Norepinephrine-induced IL-6 regulates fibrosis in systemic sclerosis
    Uehara, A.
    Yamada, K.
    Uchiyama, A.
    Ogino, S.
    Ishikawa, O.
    Motegi, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S153 - S153
  • [49] INTERLEUKIN-6 (IL-6) AUTOANTIBODIES AND BLOOD IL-6 MEASUREMENTS
    HANSEN, MB
    SVENSON, M
    DIAMANT, M
    ROSS, C
    BENDTZEN, K
    BLOOD, 1995, 85 (04) : 1145 - 1145
  • [50] STUDY OF THE ROLE OF IL-6 IN THE DEVELOPMENT OF ATHEROSCLEROSIS IN PATIENTS WITH SYSTEMIC SCLEROSIS
    Alegre Sancho, J. J.
    Robustillo Villarino, M.
    Albert Esp, G.
    Vergara Dangond, C.
    Vicens Bernabeu, E.
    Ybanez Garcia, D.
    Valls Pascual, E.
    Martinez-Ferrer, A.
    Roman Ivorra, J. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 753 - 753